Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis.

Testa, L; Latini, R A; Pizzocri, S; Lanotte, S; Agnifili, M; Laudisa, M L; Brambilla, N; Bedogni, F

Testa, L; Latini, R A; Pizzocri, S; Lanotte, S; Agnifili, M; Laudisa, M L; Brambilla, N; Bedogni, F.

Affiliation

Testa L; Interventional Cardiologist, Department of Interventional Cardiology, S. Ambrogio Clinical Institute, Milan, Italy. luctes@gmail.com

QJM ; 104(12): 1025-34, 2011 Dec.

Article in En | MEDLINE | ID: mdl-21896624

Subject(s)

Coronary Stenosis/surgery; Myocardial Infarction/epidemiology; Myocardial Revascularization/statistics & numerical data; Stents/adverse effects; Thrombosis/epidemiology; Chromium Alloys; Drug-Eluting Stents/adverse effects; Female; Humans; Immunosuppressive Agents/administration & dosage; Male; Myocardial Infarction/mortality; Paclitaxel/administration & dosage; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus/administration & dosage; Treatment Outcome; Tubulin Modulators/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thrombosis / Stents / Coronary Stenosis / Myocardial Infarction / Myocardial Revascularization Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Male Language: En Journal: QJM Year: 2011 Document type: Article

Fulltext

XML

PubMed Links

Search on Google